TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
36,806
|
40,521
|
35,904 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
2,588
|
4,284
|
4,863 |
| EBITDA |
2,698
|
4,300
|
5,028 |
| Total assets |
9,299
|
10,432
|
13,408 |
| Current assets |
8,314
|
9,293
|
12,931 |
| Current liabilities |
5,856
|
6,982
|
10,150 |
| Equity capital |
3,443
|
3,450
|
3,258 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
14
|
14
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
37.0%
|
33.1%
|
24.3% |
| Turnover per employee |
2,629
|
2,894
|
2,762 |
| Profit as a percentage of turnover |
7.0%
|
10.6%
|
13.5% |
| Return on assets (ROA) |
27.8%
|
41.1%
|
36.3% |
| Current ratio |
142.0%
|
133.1%
|
127.4% |
| Return on equity (ROE) |
75.2%
|
124.2%
|
149.3% |
| Change turnover |
-2,375
|
4,432
|
-2,229 |
| Change turnover % |
-6%
|
12%
|
-6% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
8%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.